To grow into one of the world’s largest private not-for-profit anti-drug, de-addiction treatment and education providers.
Excellence: Endeavor for providing an outstanding service in all our activities
Service orientation: Our physicians, health care workers, and educators will devote their talent and skills for betterment of humanity
Individual Dignity: While providing compassionate medical care, the dignity of the individual will be respected
Teamwork: Dedicated individuals who will use their knowledge, skills and energy in a co-operative manner to enhance committed healthcare to addiction affected individuals
Physician Leadership: We are a physician-led organisation to provide excellent medical care.
Diversity: A diverse conglomeration of physicians, nurses, other health care professionals, students and volunteers to promote healthy living.
Education: To disseminate intellectual and professional information to the public in order to maintain high standards of public health.
Fiscal Responsibility: To prudently use resources for effective and optimum use of equipment and devices.
Tradition: Our long standing commitment has been affordable care for everyone, and we take pride in this altruistic philosophy.
Under the leadership of ...
Dr. G Shreekumar Menon, IRS(Rtd) Ph.D (Narcotics)
“Spreading the vital message of the many costs and consequences of drug abuse”
Dr. G Shreekumar Menon is the retired Director General of the National Academy of Customs, Exercise-Narcotics, Faridabad, Hariyana, India. It is the premier Academy set up by the Government of India to combat the menace of Narcotic drugs. Dr. G Shreekumar Menon holds a Ph.D in Narcotics drugs and Psychotropic substances. He is an internationally renowned counter Narcotic expert and has trained personnel of Army, Navy, Police, Customs, Central Bureau of Narcotics, Narcotic Central Bureau as well as foreign military and para military forces of Afghanistan, Nepal, Bhutan, Bangladesh, Sri Lanka , and Kingdom of Saudi Arabia. Under his leadership YNEFI will be combating the increasing complex and challenging drug landscape affecting the nation.